The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer
Abstract Background Postoperative chemotherapy is an essential treatment in locally advanced colon cancer, however, effective biomarkers for predicting patients who will benefit from this therapy are lacking. This study aims to explore the clinical value of protein arginine methyltransferase 5 (PRMT...
Saved in:
| Main Authors: | Lu Lu, Huan Li, Hongfang Yin, Feng Wang, Xiaowen Sun, Yanyun Chang, Yuling Sheng, Qi Liu, Yifan Peng, Changzheng Du |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14161-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PRMT5 inhibitors: Therapeutic potential in pancreatic cancer
by: Carolin Schneider, et al.
Published: (2025-05-01) -
PRMT5 promotes cellulase production by regulating the expression of cellulase gene eg2 through histone methylation in Ganoderma lucidum
by: Yefan Li, et al.
Published: (2025-08-01) -
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer
by: Coralie Poulard, et al.
Published: (2023-07-01) -
Renal Function Deterioration in Postoperative (Adjuvant) Chemotherapy for Colon Cancer—Real-Life Data
by: Aleksandra Gładyś, et al.
Published: (2025-06-01) -
PRMT5 Promotes Pancreatic Cancer Tumorigenesis via Positive PRMT5/C‐Myc Feedback Loop
by: Fan Yang, et al.
Published: (2025-06-01)